Acute respiratory distress syndrome (ARDS)
Conditions
Interventions
Control group:Patients received high-flow humidified oxygen therapy(AIRVOTM2) utilizing a respiratory humidification therapeutic device
Experimental group:The novel developed high-flow humidification oxygen therapy device(HVHF) was utilized for both humidification and high-flow oxygen therapy
Sponsors
Shenzhen Second People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. The patient is >= 18 years old and meets the diagnostic criteria for mild to moderate ARDS; 2. The patient has an endotracheal tube (endotracheal intubation or tracheotomy tube); 3. Informed consent of the patient or (and) family members.
Exclusion criteria
Exclusion criteria: 1. Patients with pregnancy and terminal tumor; 2. History of airway injury, pulmonary trauma, lung surgery; 3. Phrenic neuromuscular injury and myasthenia gravis associated with neurological diseases; 4. Various types of shock that are difficult to correct (the mean arterial pressure is still <65mmHg in the case of vasoactive drug use).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Oxygenation Index(PaO2/FiO2); | — |
Countries
China
Contacts
Public ContactMei Yang
Shenzhen Second People's Hospital
Outcome results
None listed